// App-Quantinova.ai

POS03 : Clinical follow-up after implantation of bioresorbable drug-eluting scaffolds- a prospective single-centre experience

Researchers

Presenter

  • Markovic S

Principal Investigators

  • Walcher D

  • Dahme T

  • Rodewald C

  • Rottbauer W

  • Woehrle J

Medical Centers

  • University of Ulm, Ulm, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved